Received May 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | NT357 | IM / LA |
The evening following vaccination, Patient felt feverish, shaking chills. The next morning felt slightly off with some blurry vision. Later the afternoon of 4/21/26 she experienced a seizure after getting her hair cut without any other identifiable precipitating cause or risk factor
None known
C50.919 (Malignant neoplasm of unspecified site of unspecified female breast) E78.5 (Hyperlipidemia, unspecified) M67.20 (Synovial hypertrophy, not elsewhere classified, unspecified site) N39.3 (Stress incontinence (female) (male)) Z42.1 (Encounter for breast reconstruction following mastectomy)
Atorvastatin 10mg daily and Vitamin D3 2000IU daily
Clindamycin (rash)
MRI brain and EEG 4/22/26 in hospital unremarkable